Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double Bedtime Dosing of Immediate-release Morphine in Cancer Patients
NCT00201539Phase 3Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Apr 2002
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of morphine in cancer pain, sponsored by Norwegian University of Science and Technology. Started Apr 2002; status: completed.
02
Drugs
morphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00201539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201539.